Home › Head and Neck Cancer › Maryland
Head and Neck Cancer clinical trials in Maryland
15 studies for Head and Neck Cancer are looking for participants at sites in Maryland.
Cities in Maryland
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0112, Baltimore
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06788990[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06479811Biospecimen Procurement for Head and Neck Disorders
- Johns Hopkins Hospital Broadway Baltimore, Baltimore
- Johns Hopkins Hospital Bayview, Baltimore
- Johns Hopkins Hospital Greenspring, Baltimore
- and 3 more
RecruitingObservational study
Ages 3 to 120 · All sexes · Updated Oct 2, 2026 · NCT03429036A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 3 to 99 · All sexes · Updated Sep 28, 2026 · NCT06303180A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- United Theranostics, Glen Burnie
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07020117Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- University of Maryland Medical Center, Baltimore
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 2, 2026 · NCT04915183A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- Johns Hopkins University, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05995821Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- Johns Hopkins Hospital, Baltimore
RecruitingHealthy volunteers welcome
Ages 1 to 26 · All sexes · Updated Jun 29, 2026 · NCT05658731Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Frederick Health Hospital, Frederick
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07327489A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT06256588Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
- Johns Hopkins Hospital East Baltimore, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07209189Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Upper Chesapeake Health, Bel Air
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06088381SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.